CONMED Corporation cash flow to debt ratio of 20.44% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

CONMED Corporation's free cash flow has decreased 1.95% from $153.88M last year to $150.88M, signaling decreasing performance

CONMED Corporation's debt to equity ratio is 0.80, which means that the company's assets are unhealthy financed, signaling financial risk.

CONMED Corporation's debt has decreased relative to shareholder equity from 0.94 last year to 0.80 today, signaling strengthened financials

CONMED Corporation has a net debt to EBITDA ratio of 5.14x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

CONMED Corporation's interest coverage ratio of 4.95 indicates that earnings with good margin can cover interest payments on company debt

CONMED Corporation's profit margin has decreased (59.37%) in the last year from 10.13% to 4.12%, signaling decreasing performance

CONMED Corporation's short-term assets of $672.86M exceed its short-term liabilities of $315.04M

CONMED Corporation's return on assets of 2.46% is lower than the 5.00% threshold, indicating inefficient asset utilization

CONMED Corporation's return on equity of 5.51%, is lower than 15.00%, indicating bad performance

CONMED Corporation's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

CONMED Corporation had positive net income in 4 out of 5 years, indicating stable and consistent earnings

CONMED Corporation has positive free cash flow, indicating the company generates cash after capital expenditures

CONMED Corporation has a free cash flow yield of 10.19%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

CONMED Corporation's yearly earnings has decreased 64.47% since last year from $132.42M to $47.05M, signaling decreasing performance

CONMED Corporation's yearly revenue has increased 5.18% since last year from $1.31B to $1.37B, signaling increasing performance

ROIC 4.97% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

CONMED Corporation's 3-year revenue CAGR of 9.55% is positive, indicating growing revenue over the past 3 years

CONMED Corporation had revenue growth in 5 out of 5 years, indicating consistent revenue performance

CONMED Corporation had positive ROE in 4 out of 5 years, indicating consistent and reliable returns on equity

CONMED Corporation is undervalued relative to its fair value price of 61.11 based on Discounted Cash Flow model

CONMED Corporation has an earnings yield of 3.80%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

CONMED Corporation is overvalued relative to its fair value price of 14.32 based on EBITDA multiple model

CONMED Corporation has an EV/EBITDA ratio of 14.72x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

CONMED Corporation is undervalued relative to its fair value price of 95.60 based on Earnings Fair Value model

CONMED Corporation has a PEG-ratio under 1 which is considered undervalued

CONMED Corporation has a price-to-book ratio of 1.43x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

CONMED Corporation has a price-to-sales ratio of 1.08x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue